[Minimize kidney failure in transplantation patients with proliferation signal inhibitors]

Area of Science:

• Nephrology
• Immunosuppression
• Transplantation Medicine

Background:

• Chronic renal dysfunction frequently complicates organ transplantation.
• Glomerular filtration rate (GFR) monitoring is crucial for detecting progressive kidney dysfunction.
• Calcineurin inhibitors (CNIs) are associated with nephrotoxicity, necessitating alternative immunosuppressive strategies.

Purpose of the Study:

• To evaluate the efficacy of proliferation signal inhibitors (PSIs) in improving renal function post-transplantation.
• To assess the benefits of converting from CNIs to PSIs for managing chronic renal dysfunction.
• To explore the optimal timing for PSI conversion in kidney and liver transplant recipients.

Main Methods:

• Review of studies investigating PSI use in kidney and liver transplant patients.
• Analysis of GFR measurements before and after conversion from CNIs to PSIs.
• Comparison of outcomes based on the timing of PSI conversion.

Main Results:

• Studies in kidney transplantation indicate that early conversion to PSIs improves GFR.
• PSIs are non-nephrotoxic and can mitigate CNI-related side effects.
• PSI-based immunosuppressive regimens show promise for liver transplant patients with renal dysfunction.

Conclusions:

• Early conversion to proliferation signal inhibitors is beneficial for preserving renal function after organ transplantation.
• PSIs offer a viable strategy to reduce calcineurin inhibitor-related nephrotoxicity.
• Integrating PSIs into immunosuppressive protocols may improve outcomes for liver transplant recipients with chronic kidney disease.